Roscovitine inhibits ongoing DNA synthesis in human cervical cancer

The effect of roscovitine, a purine analogue and cyclin dependent kinase inhibitor, on DNA synthesis rate in tissue mini-units obtained from human cervical cancers was investigated. Roscovitine (100 μM) gave a DNA synthesis rate inhibition by 61% (P<0.0001; range 23-93%) within 30 min of incubati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vitali, L., Yakisich, J.Sebastian, Vita, M.F., Fernandez, A., Settembrini, L., Siden, A., Cruz, M., Carminatti, H., Casas, O., Idoyaga Vargas, V.
Formato: JOUR
Materias:
DNA
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_03043835_v180_n1_p7_Vitali
Aporte de:
id todo:paper_03043835_v180_n1_p7_Vitali
record_format dspace
spelling todo:paper_03043835_v180_n1_p7_Vitali2023-10-03T15:20:04Z Roscovitine inhibits ongoing DNA synthesis in human cervical cancer Vitali, L. Yakisich, J.Sebastian Vita, M.F. Fernandez, A. Settembrini, L. Siden, A. Cruz, M. Carminatti, H. Casas, O. Idoyaga Vargas, V. Cervical cancer Cyclin dependent kinases DNA synthesis Roscovitine roscovitine adult aged article cancer chemotherapy cancer staging cell proliferation clinical article concentration response controlled study DNA synthesis DNA synthesis inhibition drug effect female human human tissue priority journal uterine cervix cancer Adult Aged Antineoplastic Agents Cyclin-Dependent Kinases DNA Dose-Response Relationship, Drug Enzyme Inhibitors Female Humans Middle Aged Purines Time Factors Uterine Cervical Neoplasms The effect of roscovitine, a purine analogue and cyclin dependent kinase inhibitor, on DNA synthesis rate in tissue mini-units obtained from human cervical cancers was investigated. Roscovitine (100 μM) gave a DNA synthesis rate inhibition by 61% (P<0.0001; range 23-93%) within 30 min of incubation. This inhibitory effect was concentration-dependent. The results suggest that the inhibition of tumor DNA synthesis rate is due to a direct effect on the DNA synthesis machinery via presently unknown mechanisms. In addition, the potential application of CDKs inhibitors as preventive agents is discussed. © 2002 Elsevier Science Ireland Ltd. All rights reserved. Fil:Vita, M.F. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Carminatti, H. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03043835_v180_n1_p7_Vitali
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Cervical cancer
Cyclin dependent kinases
DNA synthesis
Roscovitine
roscovitine
adult
aged
article
cancer chemotherapy
cancer staging
cell proliferation
clinical article
concentration response
controlled study
DNA synthesis
DNA synthesis inhibition
drug effect
female
human
human tissue
priority journal
uterine cervix cancer
Adult
Aged
Antineoplastic Agents
Cyclin-Dependent Kinases
DNA
Dose-Response Relationship, Drug
Enzyme Inhibitors
Female
Humans
Middle Aged
Purines
Time Factors
Uterine Cervical Neoplasms
spellingShingle Cervical cancer
Cyclin dependent kinases
DNA synthesis
Roscovitine
roscovitine
adult
aged
article
cancer chemotherapy
cancer staging
cell proliferation
clinical article
concentration response
controlled study
DNA synthesis
DNA synthesis inhibition
drug effect
female
human
human tissue
priority journal
uterine cervix cancer
Adult
Aged
Antineoplastic Agents
Cyclin-Dependent Kinases
DNA
Dose-Response Relationship, Drug
Enzyme Inhibitors
Female
Humans
Middle Aged
Purines
Time Factors
Uterine Cervical Neoplasms
Vitali, L.
Yakisich, J.Sebastian
Vita, M.F.
Fernandez, A.
Settembrini, L.
Siden, A.
Cruz, M.
Carminatti, H.
Casas, O.
Idoyaga Vargas, V.
Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
topic_facet Cervical cancer
Cyclin dependent kinases
DNA synthesis
Roscovitine
roscovitine
adult
aged
article
cancer chemotherapy
cancer staging
cell proliferation
clinical article
concentration response
controlled study
DNA synthesis
DNA synthesis inhibition
drug effect
female
human
human tissue
priority journal
uterine cervix cancer
Adult
Aged
Antineoplastic Agents
Cyclin-Dependent Kinases
DNA
Dose-Response Relationship, Drug
Enzyme Inhibitors
Female
Humans
Middle Aged
Purines
Time Factors
Uterine Cervical Neoplasms
description The effect of roscovitine, a purine analogue and cyclin dependent kinase inhibitor, on DNA synthesis rate in tissue mini-units obtained from human cervical cancers was investigated. Roscovitine (100 μM) gave a DNA synthesis rate inhibition by 61% (P<0.0001; range 23-93%) within 30 min of incubation. This inhibitory effect was concentration-dependent. The results suggest that the inhibition of tumor DNA synthesis rate is due to a direct effect on the DNA synthesis machinery via presently unknown mechanisms. In addition, the potential application of CDKs inhibitors as preventive agents is discussed. © 2002 Elsevier Science Ireland Ltd. All rights reserved.
format JOUR
author Vitali, L.
Yakisich, J.Sebastian
Vita, M.F.
Fernandez, A.
Settembrini, L.
Siden, A.
Cruz, M.
Carminatti, H.
Casas, O.
Idoyaga Vargas, V.
author_facet Vitali, L.
Yakisich, J.Sebastian
Vita, M.F.
Fernandez, A.
Settembrini, L.
Siden, A.
Cruz, M.
Carminatti, H.
Casas, O.
Idoyaga Vargas, V.
author_sort Vitali, L.
title Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
title_short Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
title_full Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
title_fullStr Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
title_full_unstemmed Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
title_sort roscovitine inhibits ongoing dna synthesis in human cervical cancer
url http://hdl.handle.net/20.500.12110/paper_03043835_v180_n1_p7_Vitali
work_keys_str_mv AT vitalil roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT yakisichjsebastian roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT vitamf roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT fernandeza roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT settembrinil roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT sidena roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT cruzm roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT carminattih roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT casaso roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
AT idoyagavargasv roscovitineinhibitsongoingdnasynthesisinhumancervicalcancer
_version_ 1807323947768741888